845 results on '"Lennon, Anne Marie"'
Search Results
2. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas
3. Impact of preoperative endoscopic procedures on adverse event rates after surgical resection for main-duct and mixed-type intraductal papillary mucinous neoplasms (IPMNs)
4. Performance of explainable artificial intelligence in guiding the management of patients with a pancreatic cyst
5. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis
6. Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation
7. Classification of pancreatic cystic neoplasms using radiomic feature analysis is equivalent to an experienced academic radiologist: a step toward computer-augmented diagnostics for radiologists
8. RNA Sequencing Identifies Frequent Mitogen-activated Protein Kinase–associated Fusion Genes in Intraductal Tubulopapillary Neoplasms of the Pancreas
9. A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts
10. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts
11. Accuracy and agreement of a large panel of endosonographers for endomicroscopy-guided virtual biopsy of pancreatic cystic lesions
12. Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer
13. Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer
14. A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEǪUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
15. Assessing aneuploidy with repetitive element sequencing
16. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements
17. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals.
18. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer.
19. Comparable Cancer-Specific Mortality of Patients With Early Gastric Cancer Treated With Endoscopic Therapy vs Surgical Resection
20. Early detection of pancreatic cancer
21. RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma
22. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer
23. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions
24. Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria
25. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors
26. Pancreatic Cysts: Sinister Findings or Incidentalomas?
27. Impact of preoperative endoscopic procedures on adverse event rates after surgical resection for main-duct and mixed-type intraductal papillary mucinous neoplasms (IPMNs)
28. Real-time evaluation and adaptation to facilitate rapid recruitment in a large cohort
29. Supplementary Data Tables S1-S5 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
30. Supplementary Data 2 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
31. Data from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
32. Supplementary Data 1 from Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
33. Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
34. Detection and localization of surgically resectable cancers with a multi-analyte blood test
35. Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
36. Classification of Pancreatic Cysts in Computed Tomography Images Using a Random Forest and Convolutional Neural Network Ensemble
37. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
38. Lessons learned from 29 lymphoepithelial cysts of the pancreas: institutional experience and review of the literature
39. Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms
40. Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video)
41. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
42. Evaluation of Cystic Lesions Using EUS, MRI, and CT
43. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series
44. Hospital admission volume does not impact the in-hospital mortality of acute pancreatitis
45. Pancreatic Cystic Lesions
46. Contributors
47. Endoscopic Ultrasonography in the Evaluation of Pancreatic Cysts
48. Contributors
49. Analysis of Pancreatic Cyst Fluid
50. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.